The use of prognostic factors in metastatic renal cell carcinoma
- 1 December 2015
- journal article
- review article
- Published by Elsevier BV in Urologic Oncology: Seminars and Original Investigations
- Vol. 33 (12), 509-516
- https://doi.org/10.1016/j.urolonc.2015.08.003
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Prognostic Factors in Patients Receiving Third Line Targeted Therapy for Metastatic Renal Cell CarcinomaJournal of Urology, 2014
- Molecular Biomarkers in Advanced Renal Cell CarcinomaClinical Cancer Research, 2014
- Clinical and Molecular Prognostic Factors in Renal Cell Carcinoma: What We Know So FarHematology/Oncology Clinics of North America, 2011
- Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinomaAnnals Of Oncology, 2011
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter StudyJournal of Clinical Oncology, 2009
- Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell CarcinomaJournal of Clinical Oncology, 2005
- Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinomaCancer, 2003
- Prognostic factors of survival and rapid progression in782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’ImmunothérapieAnnals Of Oncology, 2002
- Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 2002
- Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 1999